Author:
Nordmark Eva,Hägglund Gunnar,Lauge-Pedersen Henrik,Wagner Philippe,Westbom Lena
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Boyd RN, Graham HK: Objective measures of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 1999, 6 (Suppl 4): 523-535.
2. Nordmark E, Hägglund G, Lagergren J: Part I. Cerebral palsy in Southern Sweden - prevalence and clinical features. Acta Paediatric. 2001, 90: 1271-1276. 10.1080/080352501317130317.
3. Nordmark E, Hägglund G, Lagergren J: Part II. Cerebral palsy in Southern Sweden - gross motor function and disabilities. Acta Paediatric. 2001, 90: 1277-1282. 10.1080/080352501317130326.
4. Westbom L, Hägglund G, Nordmark E: Cerebral palsy in a total population of 4-11 year olds in southern Sweden. Prevalence and distribution according to different CP classification systems. BMC Pediatrics. 2007, 7: 41-10.1186/1471-2431-7-41.
5. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV: Cerebral palsy epidemiology: where are we now and where are we going?. Dev Med Child Neurol. 1992, 34: 547-51. 10.1111/j.1469-8749.1992.tb11479.x.
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献